Bayer diabetes business sale not imminent: sources

February 20, 2015 11:40 AM

9 0

Bayer diabetes business sale not imminent: sources

FRANKFURT (Reuters) - German drugmaker Bayer is in talks to sell its diabetes devices division but a sale is not imminent, two sources with knowledge of the matter told Reuters.

Bayer is making a second attempt to sell the Contour blood glucose-meter business, which had annual sales of 722 million euros ($819 million) in 2013, as it overhauls its business to focus on margin-rich healthcare sectors.

Also read: U.S. auto sales seen up 0.5 percent in May: JD Power and LMC

Read more

To category page

Loading...